Differential changes in induced seizures after hippocampal treatment of rats with an antisense oligodeoxynucleotide to the GABA A receptor 2 subunit

By Karle J.   Laudrup P.   Sams-Dodd F.   Mikkelsen J.D.   Nielsen M.  

European Journal of Pharmacology, Vol. 340, Iss. 2, 1997-12 ,pp. : 153-160

Elsevier

Access to resources Recommend Favorite

Treatment with an antisense oligodeoxynucleotide to the GABA A receptor 2 subunit increases convulsive threshold for -CCM, a benzodiazepine 'inverse agonist', in rats

By Tai-jun Z.   Rosenberg H.C.   Chiu T.H.  

European Journal of Pharmacology, Vol. 306, Iss. 1, 1996-06 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite

Corrigendum to ``Effects of metrifonate on memory impairment and cholinergic dysfunction in rats'' [Eur. J. Pharmacol. 322 (1997) 11-19]

By Itoh A.   Nitta A.   Katono Y.   Usui M.   Naruhashi K.   Iida R.   Hasegawa T.   Nabeshima T.  

European Journal of Pharmacology, Vol. 332, Iss. 1, 1997-07 ,pp. : 113-113

Elsevier

Access to resources Recommend Favorite

An antisense oligodeoxynucleotide to -opioid receptors inhibits -opioid receptor agonist-induced analgesia in rats

By Chen X.-H.   Adams J.U.   Geller E.B.   DeRiel J.K.   Adler M.W.   Liu-Chen L.-Y.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 105-108

Elsevier

Access to resources Recommend Favorite

Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats

By Engelmann M.   Landgraf R.   Lorscher P.   Conzelmann C.   Probst J.C.   Holsboer F.   Reul J.M.H.M.  

European Journal of Pharmacology, Vol. 361, Iss. 1, 1998-11 ,pp. : 17-26

Elsevier

Access to resources Recommend Favorite